The escalating threat of antimicrobial resistance (AMR) is driving a critical expansion in the diagnostic sector, as healthcare providers seek faster and more accurate ways to determine effective treatments. The Antimicrobial Susceptibility Testing Market was valued at USD 4.24 billion in 2024 and is expected to reach USD 6.68 billion by 2032, growing at a CAGR of...